Amyloid β-induced neurotoxicity is associated with phospholipase D activation in cultured rat hippocampal cells

Neuroscience Letters

Volumn 229, Issue 1, 1997, Pages 37-40

  Cox, David A ^a   Cohen, Marlene L ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Alzheimer's disease; Amyloid protein; Phospholipase D

Indexed keywords

AMYLOID BETA PROTEIN; LACTATE DEHYDROGENASE; PHOSPHOLIPASE D;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HIPPOCAMPUS; NERVE CELL CULTURE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

AMYLOID BETA-PROTEIN; ANIMALS; CELL SURVIVAL; CELLS, CULTURED; COLORIMETRY; ENZYME ACTIVATION; HIPPOCAMPUS; L-LACTATE DEHYDROGENASE; NEURONS; NEUROTOXINS; PHOSPHOLIPASE D; RATS;

EID: 0030875648     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(97)00407-2     Document Type: Article

References (20)

1. Bonser, R.W., Thompson, N.T., Randall, R.W. and Garland, L.G., Phopholipase D activation is functionally linked to superoxide generation in the human neutrophil, Biochem. J., 264 (1989) 617-620.
2. Cox, D.A. and Cohen, M.L., Lysophophatidylcholine stimulates phospholipase D in human coronary endothelial cells: role of PKC, Am. J. Physiol., 271 (1996) H1706-H1710.
3. DeValck, D., Beyaert, R., Van Roy, F. and Fiers, W., Tumor necrosis factor cytotoxicity is associated with phospholipase D activation, Eur. J. Biochem., 212 (1993) 491-497.
4. Glenner, G.C. and Wong, C.W., Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein, Biochem. Biophys. Res. Commun., 120 (1984) 885-890.
5. Goodman, Y., Steiner, M.R. and Mattson, M.P., Nordihydrogulaiaretic acid protects hippocampal neurons against amyloid β-peptide toxicity and attenuates free radical and calcium accumulation, Brain Res., 654 (1994) 171-176.
6. Hu, C.-H., Liu, S.-Y. and Panagia, V., The transphosphatidylation activity of phospholipase D, Mol. Cell. Biochem., 157 (1996) 101-105.
7. Iversen, L.L., Mortishire-Smith, R.J., Pollack, S.J. and Shearman, M.S., The toxicity in vitro of β-amyloid protein, Biochem. J., 311 (1995) 1-16.
8. Jope, R.S., Song, L., Li, X. and Powers, R., Impaired phosphoinositide hydrolysis in Alzheimer's disease brain, Neurobiol. Aging, 15 (1994) 221-226.
9. Kanfer, J.N., Singh, I.N., Pettegrew, J.W., McCartney, D.G. and Sorrentino, G., Phospholipid metabolism in Alzheimer's disease and in a human cholinergic cell, J. Lipid. Mediat., 14 (1996) 361-363.
10. Klegeris, A., Walker, D.G. and McGeer, P.L., Interaction of Alzheimer β-amyloid peptide with the human monocytic cell line THP-1 results in a protein kinase C-dependent secretion of tumor necrosis factor-α, Brain Res., 747 (1997) 114-121.
11. Knight, J.A., Reactive oxygen species and the neurodegenerative disorders, Ann. Clin. Lab. Sci., 27 (1997) 11-25.
12. May, P.C., Gitter, B.D., Waters, B.C., Simmons, L.K., Becker, G.W., Small, J.S. and Robison, P.M., β-Amyloid in vitro toxicity: lot-to-lot variability, Neurobiol. Aging, 13 (1992) 605-607.
13. McPhail, L.C., Qualliotine-Mann, D. and Waite, K.A., Cell-free activation of neurtophil NADPH oxidase by a phosphatidic acid-regulated protein kinase, Proc. Natl. Acad. Sci. USA, 92 (1995) 7931-7935.
14. Pike, C.J., Burdick, D., Walencewicz, A.J., Glabe, C.G. and Cotman, C.W., Neurodegeneration induced by β-amyloid peptides in vitro: role of peptide assembly state, J. Neurosci., 13 (1993) 1676-1687.
15. Selkoe, D.J., Cell biology of the amyloid β protein precursor protein and the mechanism of Alzheimer's disease, Annu. Rev. Cell Biol., 10 (1994) 373-403.
16. Simmons, L.K., May, P.C., Tomaselli, K.J., Rydel, R.E., Fuson, K.S., Brigham, E.F., Wright, S., Liegerburg, I., Becker, G.W., Brems, D.N. and Li, W.Y., Secondary structure of amyloid β peptide correlates with neurotoxic activities in vitro, Mol. Pharmacol., 45 (1994) 373-379.
17. Singh, I.N., McCartney, D.G. and Kanfer, J.N., Amyloid beta protein (25-35) stimulation of phospholipase A, C and D activities of LA-N-2 cells, FEBS Lett., 365 (1995) 125-128.
18. Singh, I.N., Sorrentino, G., Sitar, D.S. and Kanfer, J.N., Indomethacin and nordihydroguaiaretic acid inhibition of amyloid β protein (25-35) activation of phospholipase A2 and D of LA-N-2 cells, Neurosci. Lett., 222 (1997) 5-8.
19. Stephenson, J., More evidence links NSAID, estrogen use with reduced Alzheimer's risk, J. Am. Med. Assoc., 275 (1996) 1389-1390.
20. Yue, T.-L., Xinkang, W., Juan-Li, G., Ruffolo, R.R. and Feuerstein, G.Z., Carvedilol prevents low-density lipoprotein (LDL)-enhanced monocyte adhesion to endothelial cells by inhibition of LDL oxidation., Eur. J. Pharmacol., 294 (1995) 585-591.